News

UC Irvine Scientists Design Bioluminescent RNA as ‘Tiny Guiding Lights’
UC Irvine scientists developed bioluminescent RNA tags, "tiny guiding lights," using luciferase to track RNA in real-time, ...
BioPharma Dive11d
Haya banks $65M to scour the ‘dark genome’ for new drugs
The startup’s first prospect is a heart medicine that works differently than the hypertrophic cardiomyopathy drugs developed ...
RNA binding proteins found essential for regulatory T cell function and immune homeostasis
Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...
JD Supra6d
Regents of the University of California v. Broad Institute (Fed. Cir. 2025)
Only a few days after the one-year anniversary of hearing oral argument, the Federal Circuit handed down its decision in ...
Corridor Business Journal4d
Integrated DNA Technologies, Aldevron pioneer first personalized CRISPR therapy powered by mRNA
Aldevron and Integrated DNA Technologies – both part of the Danaher Corporation – have achieved a medical milestone with the ...
Morningstar17d
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) HAYA Therapeutics, SA, a biotechnology company ...
Morningstar11d
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
Morningstar brands and products Company Portfolio ...
Yahoo Finance17d
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
LAUSANNE, Switzerland & SAN DIEGO, May 02, 2025--(BUSINESS WIRE)--HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that ...